Navigation Links
Dr. Brian Druker honored with Japan Prize

PORTLAND, Ore. Oregon Health & Science University congratulates Brian J. Druker, M.D., who has been awarded the 2012 Japan Prize in Healthcare and Medical Technology for his pioneering role in targeted cancer drugs. The Japan Prize is considered one of the world's most prestigious awards in science and technology. Druker's research proved it was possible to shut down cells that enable cancer to grow without harming healthy ones a discovery that helped make once-fatal forms of the disease manageable.

"On behalf of all OHSU employees, I extend our congratulations to Brian," said OHSU President Joe Robertson, M.D., M.B.A. "Brian's brilliance, hard work and dedication have impacted millions of lives. Though he has already achieved great things, Brian has maintained his fierce determination to make cancer a disease we no longer have to fear. It is impossible to not be inspired by him and want to be a part of his important mission to end cancer as we know it."

Druker shares the Japan Prize in Healthcare and Medical Technology with Nicholas B. Lydon, Ph.D., who became a founder and director of Blueprint Medicines after a career at Novartis, and Janet D. Rowley, M.D., Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at The University of Chicago. All three were involved in the scientific discoveries that led to the development of one of the first drugs to target cancer-specific molecules. In addition to the prize for Healthcare and Medical Technology, the Japan Prize Foundation also recognized Masato Sagawa, president of Intermetallics Co., with the award for Environment, Energy and Infrastructure for developing the world's highest performing permanent magnet and contributing to energy conservation.

"We're honored to give this year's awards to the four distinguished people," said Hiroyuki Yoshikawa, chairman of the Japan Prize Foundation. "They truly deserve the Japan Prize, which is given to scientists and researchers who made substantial contributions not only scientifically but also to promoting the advancement of science and technology for the peace and prosperity of mankind."

The Japan Prize Laureates will be formally honored at a Presentation Ceremony in Tokyo on April 25.

"I am honored to receive this distinguished award. It is most meaningful to me because the research it recognizes brings hope to cancer patients and their families," said Druker, director of the Oregon Health & Science University Knight Cancer Institute, a Howard Hughes Medical Institute Investigator and JELD-WEN Chair of Leukemia Research at OHSU. "My goal going forward is to advance science so that someday there will be a targeted therapy to shut down every form of cancer."

Druker began his cancer research career in the 1980s, studying why some formerly normal cells shift into overdrive producing tumors. In 1993, the year he joined OHSU, Druker began testing compounds that could target the molecules that drive chronic myloid leukemia (CML). He identified the compound that ultimately became Gleevec and then led the drug's clinical trials. During the trials, nearly all CML patients saw their white blood counts return to normal in a matter of weeks with little or no side effects. Patients in hospice facilities, who were expecting to die within days, recovered and began leading normal lives and are still alive today. The trials were so successful that they resulted in the fastest approval by the FDA in its history.

Since Gleevec was approved by the FDA in 2001 to treat CML, it has since been proven effective against multiple forms of cancer including pediatric CML and gastrointestinal stromal tumor (GIST). Gleevec's success has since led to the development of dozens of other FDA-approved targeted therapies and even more that are in clinical trials or about to be approved.

With his scientific and medical achievements, Druker has steadily built the OHSU Knight Cancer Institute into an international leader in delivering personalized cancer medicine. Public support through the National Institutes of Health and the Oregon Opportunity research investment has been joined with generous private donations including the transformative $100 million gift from Phil and Penny Knight, the $5 million gift from John Gray and the $2.5 million gift from the Boyle family. These investments have enabled Druker to recruit some of the world's top scientists to write the assembly manual for cancer. By figuring out how cancer cells function and why they grow out of control, researchers will have the knowledge they require to develop the drugs to stop it.

Contact: Elisa Williams
Oregon Health & Science University

Related medicine news :

1. ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier
2. "How Facebook Makes Lonely People Even Lonelier" Revealed by Distinguished University of Chicago Professor in Interview with Brian Vaszily on
3. Brian Fox to Speak on Audit Confirmation Fraud at the 2010 IAPP Annual Forum and Expo
4. Champion Nutrition Announces the Signing of Brian Bowles
5. Cleveland Clinic researchers honored for contributions to science
6. UC Riverside toxicologist honored by international academy
7. Office of Naval Research young investigators honored with Presidential Award
8. Community leaders honored for helping Americans most in need
9. Founder of international telecom company and more to be honored by NJIT
10. Physician honored for medical contributions in US and Armenia
11. Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe ... and IV sedation dentistry for more than 5 years. A leading cause ... serious and painful if treatment is not timely. , Sedation dentistry ...
(Date:10/13/2015)... ... 13, 2015 , ... California Southern University has named Dr. ... her Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern ... Dr. McLeod’s long and successful nursing practice included a variety of patient care, ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... 2015 , ... Local Gold’s Gym franchise owner, Bryce Berry, received the Visionary ... who owns and operates Gold's Gym Cheyenne in Cheyenne, Wyoming, received the ... United States. A brand leader in global fitness, Gold’s Gyms are located worldwide. Every ...
(Date:10/13/2015)... ... 13, 2015 , ... According to an ESPN report published on ... teammate accidentally elbowed him in the left eye during the first day of practice ... of a series of setbacks, including a knee injury that has interfered with his ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Elbit Imaging Ltd. ("EI" or the ... board of directors approved a program to repurchase up to ... H Notes and Series I Notes, which are traded on ... the Company will have a significant preference to the purchase ... to time in the open market on the Tel Aviv ...
(Date:10/12/2015)... ) ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Industry Trends, Technologies, Participants, and Environment" ... ) has announced the addition of ... Companion Diagnostic Market to 2019 - Strategic ...
(Date:10/12/2015)... , October 12, 2015 ... interest from pharmaceutical companies as they look to ... others appear in a new report by  visiongain ... market gains much interest from pharmaceutical companies as ... finding and many others appear in a new ...
Breaking Medicine Technology: